Tirzepatide (Mounjaro, Zepbound), while often grouped with GLP-1 medications, is technically a dual GIP/GLP-1 receptor agonist but follows similar storage requirements
Posted March 25, 2020 Reviewed by Kaja Perina Severe dementia, neuropathies (painful nerves), mood disorders, attention deficit, and minor memory issues like inability to remember important dates or events are common problems
October 2025
H-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH 2 2CF 3 COOH ( 13 ) Protected cyclic hexapeptide 12 (8.2 g, 6.66 mmol) was dissolved in dry methanol (220 mL) and Pd(OH) 2 (0.3 g) was added
Most common include: Mild irritation at the injection site Nausea, bloating, or stomach cramps Mild sulfur (rotten egg) taste in the mouth Rare but serious: Allergic reactions (hives, swelling of face/lips/tongue/throat, difficulty breathing)
OEM and ODM Services: Full customization and flexible design options available